# ImmunityBio, Inc.: Form 8-K, filed Aug 24, 2020

- Company: [ImmunityBio, Inc.](/companies/ibrx.md) (CIK 1326110)
- Form: 8-K
- Filed: 2020-08-24
- Accepted by EDGAR: Aug 24, 2020, 16:10 ET
- Period: 2020-08-21
- Accession: 0001193125-20-228341
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1326110/000119312520228341/d72712d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1326110/000119312520228341/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1326110/000119312520228341/d72712d8k.htm

Filed Aug 24, 2020.
Source: SEC EDGAR, the filing index for accession 0001193125-20-228341. Last ingested by Listed: Nov 9, 2026, 17:45 ET. No prices; not investment advice.
